Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: Results from the spirit III and spirit IV clinical trials

Journal of Interventional Cardiology

Volumn 24, Issue 6, 2011, Pages 505-513

  Ito, Hiroki ^a   Hermiller, James B ^a   Yaqub, Manejeh ^b   Newman, William ^c   Sood, Poornima ^b   Wang, John C ^d   Cannon, Louis ^e   Maddux, James E ^f   Sudhir, Krishnankutty ^b   Stone, Gregg W ^g  

^a St Vincent Heart Center of Indiana   (United States)

^b ABBOTT VASCULAR   (United States)

^c WAKEMED HEALTH AND HOSPITALS   (United States)

^d UNION MEMORIAL HOSPITAL   (United States)

^e Northern Michigan Regional Hospital   (United States)

^f St Patrick Hospital and Health Sciences Center   (United States)

^g Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY; CORONARY STENT; DIABETIC PATIENT; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; SINGLE BLIND PROCEDURE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR DISEASE;

ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; RISK FACTORS; SIROLIMUS; STATISTICS AS TOPIC;

EID: 83955164242     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00664.x     Document Type: Article

References (22)

1. Schunkert H, Harrell L, Palacios IF,. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999; 34: 40-8.
2. Elezi S, Kastrati A, Neumann FJ, et al,. Vessel size and long-term outcome after coronary stent placement. Circulation 1998; 98: 1875-1880. (Pubitemid 28509283)
3. Jabara R, Gradman M, Chen JP, et al,. Clinical and angiographic features of small vessel stenting in the drug-eluting stent era. Clin Cardiol 2009; 32: E40-E45.
4. Cutlip DE, Baim DS, Ho KK, et al,. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971. (Pubitemid 32322224)
5. Roguin A, Grenadier E,. Stent-based percutaneous coronary interventions in small coronary arteries. Acute Card Care 2006; 8: 70-74. (Pubitemid 44034756)
6. Hermiller JB, Fergus T, Pierson W, et al,. Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial. Am Heart J 2009; 158: 1005-1010.
7. Stone GW, Midei M, Newman W, et al,. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008; 299: 1903-1913. (Pubitemid 351574920)
8. Stone GW, Rizvi A, Newman W, et al,. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010; 362: 1663-1674.
9. Stone GW, Ellis ES, Cox DA, et al,. A polymer based, paclitaxel-eluting stent in patients with coronary artery diseases. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
10. Stone GW, Ellis SG, Cox DA, et al,. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942-1947. (Pubitemid 38544483)
11. Morice MC, Serruys PW, Sousa JE, et al,. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780. (Pubitemid 34586912)
12. Ellis SG, Popma J, Lasala JM, et al,. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: Analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005; 45: 1193-1200. (Pubitemid 40523136)
13. Mauri L, Orav EJ, O'Malley AJ, et al,. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 2005; 111: 321-327. (Pubitemid 40165339)
14. Moses JW, Leon MB, Popma JJ, et al,. Sirolimus-eluting versus standard stents in patients with stenosis in a native corornary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
15. Serruys PW, Ruygrok P, Neuzner J, et al,. A randomized comparison of an everolimus eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. EuroInterv 2006; 2: 286-294.
16. Tsuchida K, Piek JJ, Neumann FJ, et al,. One-year results of a durable polymer everolimus eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). Euro Interv 2005; 1: 266-272.
17. Baran KW, Lasala JM, Cox DA, et al,. A clinical risk score for prediction of stent thrombosis. Am J Cardiol 2008; 102: 541-545.
18. Holmes DR, Jr, Kereiakes DJ, Laskey WK, et al,. Thrombosis and drug-eluting stents, an objective appraisal. J Am Coll Cardiol 2007; 50: 109-118. (Pubitemid 47007739)
19. Moreno R, Fernandez C, Alfonso F, et al,. Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies. J Am Coll Cardiol 2004; 43: 1964-1972. (Pubitemid 38686789)
20. Palmaz JC, Bailey S, Marton D, et al,. Influence of stent design and material composition on procedure outcome. J Vasc Surg 2002; 36: 1031-1039. (Pubitemid 35316081)
21. Pache J, Kastrati A, Mehilli J, et al,. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003; 41 (8): 1283-1288. (Pubitemid 36438988)
22. Kedhi E, Joesoef KS, McFadden E, et al,. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomized trial. Lancet 2010; 375: 201-209.